New research reveals PD-1 inhibitors may compromise the blood-brain barrier, influencing cancer treatment outcomes and brain ...

Dr. Sandeep Kunwar explained that getting drugs into the brain is a major hurdle for glioblastoma, as the blood-brain barrier blocks most treatments. Dr. Sandeep Kunwar, a neurosurgeon and professor ...

Getting therapeutic drugs past the blood-brain barrier has long been a major challenge in treating brain diseases. Now, researchers have explored how cholesterol-modified heteroduplex oligonucleotides ...

Our brain is a fortress. Its delicate interior is completely surrounded by a protective wall called the blood-brain barrier. True to its name, the barrier separates contents in the blood and the brain ...

(OTCQB: OTLC) (profile) are responding to this challenge with next-generation delivery platforms engineered to circumvent biological barriers and ensure direct, targeted access to the central nervous ...

Oligonucleotide therapeutics, including antisense oligonucleotides and small interfering ribonucleic acid (RNA), have emerged as powerful tools for regulating gene expression and treating neurological ...

Beyond chronic diseases, CNS drug delivery is also a critical factor in biodefense and national security. As traditional drug-delivery approaches continue to face limitations, alternative methods ...

Found in everything from protein bars to energy drinks, erythritol has long been considered a safe alternative to sugar.

Scientists are creating a glioblastoma 'tumor on a chip'—a tiny living system capable of mimicking the key features of the ...

Multiple sclerosis (MS) is a chronic autoimmune disease in which the immune system targets the myelin sheath coating nerves.